Philips Lumify handheld ultrasound solution launched in Japan to enable powerful diagnostics at the bedside
June 11 2020 - 04:00AM
Philips Lumify handheld ultrasound solution launched in Japan to
enable powerful diagnostics at the bedside
June 11, 2020
- Philips’ Lumify handheld diagnostic ultrasound solution with
telehealth capabilities meets the demands of Japan’s changing
healthcare demographics
- Optional Lumify with Reacts capability adds tele-ultrasound to
enable healthcare professionals to remotely collaborate and
exchange expert advice during diagnosis
- Solution also recognized for benefit to humankind by IEEE
Spectrum
Amsterdam, the Netherlands – Royal
Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, today announced that its Lumify with Reacts
handheld tele-ultrasound solution is now commercially available in
Japan. Philips has received clearance from Japan’s healthcare
authority to introduce the ultrasound solution for compatible
handheld devices [1] in the world’s third largest healthcare market
after the US and China. Launched in Japan with a novel subscription
model unique in the industry, Philips’ tele-ultrasound solution
aims to make high-quality portable ultrasound available almost
everywhere in the country.
Improving the diagnostic imaging experience for patients and
staffJapan’s declining birthrate and aging population makes the
need for medical diagnostic equipment that can adapt to these
changing demographics more relevant than ever. The portability of
Lumify brings a powerful portable diagnostic solution to care
professionals in the hospital, enabling them to use ultrasound
imaging for bedside diagnosis and to monitor medical conditions.
Additionally, Lumify can be easily taken to community settings at
the point of care, helping to reduce the need for elderly people to
travel to hospitals in Japan’s larger cities.
"By bringing diagnostic insight to the point of care, Lumify is
a great example of how Philips is supporting providers to deliver
on the ambition of the ‘quadruple aim’ in healthcare: better health
outcomes, an improved experience for patients and staff, and a
lower cost of care,” said Matthijs Groot Wassink, General Manager
for Access and Obstetric Ultrasound at Philips. “Its transducer
connects to a smart device such as a tablet, making it a compact
and highly durable solution. In addition, by utilizing Philips’
Lumify with Reacts capability, real-time ultrasound images can be
shared between medical staff involved in collaboration during
imaging procedures.”
Highly versatile, app-based mobile ultrasound Lumify is a
highly versatile solution primarily intended for use in places
where quick and easy access to diagnostic ultrasound imaging is
required. Its portability and ruggedness make it suitable for
point-of-care use both in hospitals and in places like ambulances,
doctor’s offices, and patients’ homes during GP visits. It is also
used in remote community healthcare programs such as mother &
childcare projects being rolled out by Philips and the Philips
Foundation in Africa. In addition to allowing clinicians to
remotely collaborate by sharing ultrasound images in real time,
Lumify’s tele-ultrasound capabilities (Lumify with Reacts) can also
be used in medical student and healthcare worker remote training
programs.
Philips is a leader in ultrasound solutions with a large global
installed base and a strong track record of industry-first
innovations in areas such as 3D imaging of the heart, AI-powered
quantification tools, and ultra-mobile portable ultrasound
solutions. Its ultrasound portfolio supports the effective and
efficient delivery of care across a broad range of clinical
specialties including radiology, cardiology, point-of-care and
obstetrics/gynecology.
Mobilizing Philips’ resources to combat COVID-19Handheld
and portable ultrasound solutions in particular have become
valuable tools for clinicians treating COVID-19 patients due to
their imaging capabilities, portability and ease of disinfection.
Philips ultrasound solutions have been approved in various markets
for the management of COVID-19-related lung and cardiac
complications, including in Australia, Brazil, Canada, the EU, New
Zealand and the US.
Philips has a comprehensive portfolio of services and solutions
which can help to support the delivery of high-quality care to
COVID-19 patients. It includes secure, connected and intelligent
approaches to diagnosis, treatment and predictive monitoring in the
hospital, plus screening, remote patient monitoring and care at
home. With healthcare under more pressure than ever before,
Philips’ telehealth and AI-enabled data analytics can help support
workflows, facilitate remote collaboration and optimize resources.
Philips’ COVID-19-related solutions are designed for rapid
deployment and scalability. For more information on how Philips is
addressing COVID-19 globally, please visit the Philips centralized
COVID-19 hub.
Lumify awarded for benefit to humankindToday, Philips
also announced that Lumify has received the 2020 IEEE Spectrum
Technology in the Service of Society Award as the technology having
the greatest potential to provide the most overall benefit to
humankind.
For information on Philips’ ultrasound solutions, visit
https://www.usa.philips.com/healthcare/solutions/ultrasound
[1] In Japan, the local health authority has approved Lumify for
use with Panasonic’s medical-grade handheld devices.
For further information, please contact:
Hans DriessenPhilips Global Press OfficeTel.: +31 6 10 61 04
17E-mail: hans.driessen@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
enabling better outcomes across the health continuum from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2019
sales of EUR 19.5 billion and employs approximately 81,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.
- Lumify abdominal scan
- Lumify with Reacts on tablet
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Feb 2024 to Mar 2024
Koninklijke Philips NV (EU:PHIA)
Historical Stock Chart
From Mar 2023 to Mar 2024